alexa Abstract | Insomnia: Current Treatment and Recent Advances

Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Review Article Open Access


Insomnia is defined as difficulty with the initiation, maintenance, duration or quality of sleep which affects daytime functioning. About one third of world population suffer from insomnia. It can be classified by various ways i.e. primary or secondary; transient, short term or chronic insomnia; or difficulty in onset or difficulties in maintaining sleep. The derangement of various neurotransmitters e.g. histamine, orexins, noradrenaline, acetylcholine and serotonin leads to insomnia. Predisposing conditions leading to insomnia are familial or genetic tendency, illness, stress and maladaptive sleep habits. Insomnia leads to chronic fatigue, inattention, irritability, emotional outbursts, absence from work, diminished productivity, risk of accidents and other health related problems. The treatment options for insomnia include cognitive behavioural therapy, pharmacological therapy and combined approach. Cognitive behavioural therapy includes stimulus control therapy, sleep restriction therapy, relaxation therapy, sleep hygiene and cognitive therapy. The pharmacological options currently widely in use are benzodiazepines and Z-drugs. Alternative drug delivery methods and innovative treatments hold promise for increasing access to care and accelerating improvement. The newer targets for treatment of insomnia are orexin receptors, melatonin receptors and serotonin receptors. A combined approach of pharmacological treatment, cognitive behavioural treatment and newer formulations for improving drug delivery is required to combat the problem of insomnia.

To read the full article Peer-reviewed Article PDF image

Author(s): Dhiren M. Pranami, Jyoti Kaushal, Garima Bhutani


Cognitive behavioural therapy in insomnia, insomnia, new drugs for insomnia, orexin receptor antagonists, recent advances in insomnia, Pharmaceutical Technology,Biopharmaceutics,Insomnia

Recommended Journals

Share This Page

Additional Info

Loading Please wait..
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version